Swiss Market Ends On Firm Note Again

Swiss stocks ended higher for a third straight session, with the SMI rising 0.45% to 13,910.70 after a flat trading day, outperforming a broadly weaker European market. The move was supported by gains in heavyweight healthcare and consumer names such as Lindt & Spruengli, Lonza, Novartis, Roche and Nestle, while losses in VAT Group, ABB, Richemont, UBS Group and others limited the advance. The article also noted Swiss National Bank data showing the country’s current account surplus narrowed sharply to CHF 15.5 billion in Q1 2026 from CHF 26.7 billion a year earlier. Overall, the tone was mildly positive for Swiss equities, but the broader market backdrop remained cautious due to concerns about stretched tech valuations and potential interest-rate hikes from the Fed and other central banks.